Colgate-Palmolive Company

(New York Stock Exchange)
Bullish +65

Aristotle Atlantic Partners LLC Makes New $1.02 Million Investment in ...

πŸ“ˆ Aristotle Atlantic Partners LLC purchased 12,000 shares of Colgate-Palmolive (NYSE:CL) worth approximately $1.02 million in the first quarter.

πŸ“Š Multiple institutional investors including Kemnay Advisory Services Inc., CBIZ Investment Advisory Services LLC, TD Capital Management LLC, Triumph Capital Management, and Jessup Wealth Management Inc. increased their stakes in the fourth quarter.

🏦 Hedge funds and other institutional investors now own 80.41% of Colgate-Palmolive's outstanding stock.

πŸ“‰ Wall Street Zen downgraded Colgate-Palmolive from a 'buy' to a 'hold' rating on March 29th.

πŸ” Goldman Sachs, Deutsche Bank, and Citigroup maintained or upgraded their 'buy' ratings with price targets ranging from $85.00 to $110.00.

πŸ’° The stock currently has an average analyst rating of 'Moderate Buy' with a consensus price target of $97.82.

πŸ“ˆ Shares of CL opened at $90.74, trading above its 50-day moving average of $90.77 and below its 200-day moving average of $88.96.

πŸ’΅ Colgate-Palmolive reported quarterly earnings of $0.97 per share, beating analyst estimates of $0.94 by $0.03.

πŸ“ˆ Revenue reached $5.32 billion during the quarter, surpassing consensus estimates of $5.22 billion.

πŸ“Š The company achieved a net margin of 10.04% and a return on equity of 386.76% for the quarter.

πŸš€ Revenue grew 8.4% compared to the same quarter last year, indicating strong consumer demand.

πŸ’Έ Analysts forecast an annual EPS of 3.81 for the current year based on current performance trends.

πŸ’° The company declared a quarterly dividend of $0.53 per share, payable on August 14th to shareholders of record as of July 20th.

πŸ“ˆ The dividend represents an annualized yield of 2.3% with a payout ratio of 82.49%.

🏒 Colgate-Palmolive operates in oral care, personal care, home care, and pet nutrition segments globally.

πŸ“‰ The stock has a market cap of $72.61 billion and a P/E ratio of 35.31.

πŸ“Š The company's debt-to-equity ratio is 16.33 with a current ratio of 1.02 and quick ratio of 0.67.

πŸ“ˆ The stock has a beta of 0.33, indicating lower volatility compared to the broader market.

πŸ“‰ The 1-year low for CL is $74.54 and the 1-year high is $99.33.

πŸ” Twelve investment analysts have rated the stock with a 'Buy' rating while seven have assigned a 'Hold' rating.

Bullish Signals
  • Aristotle Atlantic Partners LLC acquired a new stake of 12,000 shares valued at approximately $1.02 million in the first quarter.
  • Multiple institutional investors including Kemnay Advisory Services Inc., CBIZ Investment Advisory Services LLC, TD Capital Management LLC, Triumph Capital Management, and Jessup Wealth Management Inc. increased their stakes in the fourth quarter.
  • Hedge funds and other institutional investors now own 80.41% of Colgate-Palmolive's outstanding stock.
  • Goldman Sachs, Deutsche Bank, and Citigroup maintained or upgraded their 'buy' ratings with price targets ranging from $85.00 to $110.00.
  • The stock currently has an average analyst rating of 'Moderate Buy' with a consensus price target of $97.82.
  • Shares of CL opened at $90.74, trading above its 50-day moving average of $90.77 and below its 200-day moving average of $88.96.
  • Colgate-Palmolive reported quarterly earnings of $0.97 per share, beating analyst estimates of $0.94 by $0.03.
  • Revenue reached $5.32 billion during the quarter, surpassing consensus estimates of $5.22 billion.
  • The company achieved a net margin of 10.04% and a return on equity of 386.76% for the quarter.
  • Revenue grew 8.4% compared to the same quarter last year, indicating strong consumer demand.
  • Analysts forecast an annual EPS of 3.81 for the current year based on current performance trends.
  • The company declared a quarterly dividend of $0.53 per share, payable on August 14th to shareholders of record as of July 20th.
  • The dividend represents an annualized yield of 2.3% with a payout ratio of 82.49%.
Full Analysis
Aristotle Atlantic Partners LLC acquired a new stake of 12,000 shares in Colgate-Palmolive Company (NYSE:CL) valued at approximately $1.02 million during the first quarter. Several other institutional investors, including Kemnay Advisory Services Inc., CBIZ Investment Advisory Services LLC, TD Capital Management LLC, Triumph Capital Management, and Jessup Wealth Management Inc., also increased or initiated positions in the fourth quarter, collectively raising hedge fund ownership to 80.41% of the company's stock. Wall Street analysts have issued mixed ratings on Colgate-Palmolive, with Goldman Sachs, Deutsche Bank, and Citigroup maintaining or upgrading 'buy' ratings, while Wall Street Zen downgraded the stock to a 'hold.' The consensus price target stands at $97.82, with an average rating of 'Moderate Buy.' Recent financial data shows the stock trading around $90.74, supported by strong earnings performance and a solid balance sheet. Colgate-Palmolive reported quarterly earnings of $0.97 per share, beating analyst estimates of $0.94, with revenue reaching $5.32 billion against a consensus of $5.22 billion. The company achieved a net margin of 10.04% and a return on equity of 386.76%, with revenue growing 8.4% year-over-year. Analysts forecast an annual EPS of 3.81 for the current year, reflecting continued operational strength in its core consumer products portfolio. The company declared a quarterly dividend of $0.53 per share, payable on August 14th to shareholders of record as of July 20th, representing an annualized yield of 2.3%. With a market capitalization of $72.61 billion and a P/E ratio of 35.31, Colgate-Palmolive continues to demonstrate resilient financial health across its oral care, personal care, home care, and pet nutrition segments.